our services

Litigation Economics

Rigorous economic analysis and expert testimony for attorneys and law firms

litigation economics

Capabilities

Litigation Economics (also referred to as Forensic Economics) refers to the application of economic theory and methods to a variety of disputes and litigation. Avalon Health Economics services in Litigation Economics provides a wide range of services related to the application of theory and tools from the fields of economics, epidemiology, biostatistics, and data analytics to a variety of dispute and litigation settings. Our core competencies are in the intersection of the standard tools of forensic economics and the novel tools of advanced data analytics and real-world evidence, supported by our deep experience in research and consulting in healthcare and life sciences.

Our range of services includes:

Expert Testimony
Faq Icon
Forensic Economics
Faq Icon
Damages Calculations
Faq Icon
Medical Billing, Reasonable Value & Fair Market Value
Faq Icon
Medical Coding
Faq Icon
Life Care Plans & Medical Necessity
Faq Icon
Life Expectancy & Work-Life Expectancy
Faq Icon
Wage Loss & Workers' Compensation
Faq Icon
Medicare & Medicaid Cost Analysis
Faq Icon
Medical Products Liability
Faq Icon
Malpractice
Faq Icon
Commercial Disputes
Faq Icon
Inflation & Net Present Value
Faq Icon
Competition & Markets
Faq Icon
litigation economics

Examples of Engagements

We serve a wide variety of clients throughout the U.S. and globally, including law firms, manufacturers, healthcare companies, and insurance companies. We have applied our expertise in litigation support to a variety of industries, including transportation, manufacturing, hospitality, construction, pharmaceuticals, medical devices, insurance, medical care, and finance.

Examples of engagements include:

  • Calculation of reasonable and fair market value of past and future medical care expenses in personal injury cases
  • Economic and epidemiological assessment of causal factors in national opioid multi-district litigation
  • Calculation of comorbidity-adjusted life expectancy and work-life expectancy in personal injury cases
  • Economic analysis of market factors in a medical products multi-district litigation matter
  • Calculation of attributable costs and abatement costs in national opioid multi-district litigation
  • Economic analysis of damages in a biotechnology investor lawsuit
  • Development of a supply and demand model for regulated product in a product liability case
  • Calculation of usual, customary and reasonable (“UCR”) payment in insurer-pharmacy benefit manager dispute
  • Calculation of usual, customary and reasonable value in out-of-network reimbursement dispute
litigation economics

Reasonable & Fair Market Value in Personal Injury & Product Liability Cases

In personal injury and product liability matters, claimed medical losses and damages are often expressed as their original charged or billed amounts. While this might make sense in many industries, it doesn’t make sense in the health industry. Charges for the exact same service in the exact same geographic area vary substantially, even after statistically adjusting for differences in input prices (like wages) and patient characteristics. This is because of a fundamental disconnect between medical care prices and the associated value of those services. Why the disconnect? Three reasons. First, as the U.S. health care system grew rapidly following World War II, the industry was largely organized as non-profit. As the industry expanded, policymakers expected non-profit entities to offer sufficient levels of “charity” care to justify their tax-exempt status; that is, to show evidence of “community benefit.” One way for healthcare providers to report high levels of charity care was to keep their charges high, accept lower rates on a per case basis, and classify the difference as either charity care or bad debt.

Read more...
litigation economics

Development of a Literature-Based Adjusted Attributable Cost Ceiling Model

In the upcoming book The Economics of Pain (Palgrave Macmillan), Schneider provides an in-depth analysis of the U.S. opioid crisis from the perspective of economics and medical products liability. One of the topics explored in the 2026 book is the development of a “cost ceiling model” based on the extensive literature on the attributable costs of the opioid crisis. In litigation the concept of damages often aligns with what health researchers and health economists typically refer to as attributable costs. The methodological approach was to make use of the peer reviewed literature on opioid attributable costs, adjusting those data to reflect the costs at issue in the opioid multi-district litigation, which is focused on prescription opioids and costs incurred by state and local governments. The goal was to calculate an “attributable cost ceiling,” which is the most likely attributable amount faced by state and local governments. A meta-analysis was conducted of peer reviewed published studies that estimated costs associated with healthcare, the criminal justice system, and social and family assistance programs.

Read more...